Behavioral Testing for Therapeutic Outcome Measurements in an Animal Model of Huntington's Disease
Sung-Rae CHO; Eun-Sook PARK; Hyun-Ok KIM; Dong-Goo KIM; Chang-Il PARK.
Journal of the Korean Academy of Rehabilitation Medicine
; : 503-511, 2007.
ArtÃculo en Ko | WPRIM | ID: wpr-724417
Documentos relacionados
Environmental stimulation in Huntington disease patients and animal models.
Dietary fibre confers therapeutic effects in a preclinical model of Huntington's disease.
Rnq1! You are still dangerous, but you can be my wingman anytime.
A platform to induce and mature biomolecular condensates using chemicals and light.
A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development.
Intellectual Curiosity and Action Initiation are Subtypes of Apathy Affected in Huntington Disease Gene Expansion Carriers.
Conditional Gaussian graphical model for estimating personalized disease symptom networks.
A fully humanized transgenic mouse model of Huntington disease.
Huntingtin Interacting Proteins and Pathological Implications.
Transplanted human neural stem cells rescue phenotypes in zQ175 Huntington's disease mice and innervate the striatum.